SCPS - Scopus BioPharma Inc.
NASDAQ
->
Healthcare
->
Biotechnology
New York,
United States
Type: Equity
SCPS price evolution
SCPS
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.36 | $1.4 | $0.12 | $0.31 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $0.5 | $1.6 | $0.39 | $0.41 |
| Long term investments | ||||
| Property, plant & equipment | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0 | $0 | $0 | $0 |
| Total investments | ||||
| Total assets | $0.5 | $1.6 | $0.39 | $0.42 |
| Current liabilities | ||||
| Accounts payable | $10.91 | $9.15 | $7.2 | $5.92 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $11 | $9.31 | $7.45 | $5.92 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $11 | $9.31 | $7.45 | $5.92 |
| Shareholders' equity | ||||
| Retained earnings | -$58.13 | -$55.51 | -$53.06 | -$51.33 |
| Other shareholder equity | $0.03 | $0.01 | -$0 | -$0 |
| Total shareholder equity | -$9.45 | -$6.95 | -$6.56 | -$5.5 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.12 | $7.94 | $1.83 | $0.04 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $0.39 | $8.18 | $1.97 | $0.77 |
| Long term investments | ||||
| Property, plant & equipment | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0 | $0 | $0 | $0 |
| Total investments | ||||
| Total assets | $0.39 | $8.19 | $1.97 | $0.77 |
| Current liabilities | ||||
| Accounts payable | $7.2 | $4.17 | $1.52 | $0.85 |
| Deferred revenue | ||||
| Short long term debt | $2.28 | |||
| Total current liabilities | $7.45 | $4.17 | $3.81 | $0.85 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | $2.28 | |||
| Total liabilities | $7.45 | $4.17 | $3.81 | $0.85 |
| Shareholders' equity | ||||
| Retained earnings | -$53.06 | -$41.46 | -$14.5 | -$3.64 |
| Other shareholder equity | -$0 | -$0.09 | -$1.57 | -$0.03 |
| Total shareholder equity | -$6.56 | $4.02 | -$1.83 | -$0.08 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $1.99 | $1.61 | $0.75 | $0.92 |
| Selling, general & administrative | $0.94 | $1.07 | $1.09 | $0.98 |
| Total operating expenses | $2.93 | $2.68 | $1.84 | $1.9 |
| Operating income | -$2.93 | -$2.68 | -$1.84 | -$1.9 |
| Income from continuing operations | ||||
| EBIT | -$2.62 | -$2.45 | -$1.73 | -$1.9 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$2.62 | -$2.45 | -$1.73 | -$1.9 |
| Income (for common shares) | -$2.62 | -$2.45 | -$1.73 | -$1.9 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $2.68 | $15.02 | $7.42 | $0.46 |
| Selling, general & administrative | $9.03 | $12.61 | $2.73 | $2.23 |
| Total operating expenses | $11.71 | $27.63 | $10.16 | $2.69 |
| Operating income | -$11.71 | -$27.63 | -$10.16 | -$2.69 |
| Income from continuing operations | ||||
| EBIT | -$11.61 | -$26.18 | -$10.16 | -$2.69 |
| Income tax expense | ||||
| Interest expense | $0.77 | $0.71 | ||
| Net income | ||||
| Net income | -$11.61 | -$26.95 | -$10.86 | -$2.69 |
| Income (for common shares) | -$11.61 | -$26.95 | -$10.86 | -$2.69 |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Net income | -$2.62 | -$2.45 | -$1.73 | -$1.9 |
| Operating activities | ||||
| Depreciation | $0 | $0 | $0 | $0 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.08 | $0.08 | $0.08 | $0.08 |
| Total cash flows from operations | -$1.01 | -$0.76 | -$0.42 | -$0.85 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.04 | $2.02 | ||
| Net borrowings | ||||
| Total cash flows from financing | -$0.04 | $2.02 | $0.24 | |
| Effect of exchange rate | $0.01 | $0.02 | -$0.01 | $0.01 |
| Change in cash and equivalents | -$1.04 | $1.28 | -$0.19 | -$0.85 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$11.61 | -$26.95 | -$10.86 | -$2.69 |
| Operating activities | ||||
| Depreciation | $0 | $0 | $0 | $0 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.35 | $0.67 | $0.29 | $0.12 |
| Total cash flows from operations | -$8.13 | -$11.42 | -$2.53 | -$2.12 |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0 | -$0 | |
| Investments | ||||
| Total cash flows from investing | -$0 | -$0 | -$0 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $17.84 | $2.42 | $2.4 | |
| Net borrowings | -$0.1 | $1.93 | ||
| Total cash flows from financing | $0.24 | $17.56 | $4.35 | $2.18 |
| Effect of exchange rate | $0.07 | -$0.02 | -$0.03 | -$0.02 |
| Change in cash and equivalents | -$7.82 | $6.11 | $1.8 | $0.04 |
News
|
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's...
Investing.com
19 Dec 2022
|
|
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.25% By Investing.com
Investing.com
16 Dec 2022
|
|
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session By...
Investing.com
20 Oct 2022
|
|
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.33% By Investing.com
Investing.com
19 Oct 2022
|
|
75 Biggest Movers From Yesterday
Benzinga
22 Mar 2022
|
|
64 Biggest Movers From Yesterday
Benzinga
18 Mar 2022
|
|
60 Biggest Movers From Yesterday
Benzinga
18 Feb 2022
|
|
56 Biggest Movers From Yesterday
Benzinga
17 Feb 2022
|
|
Mid-Morning Market Update: Markets Open Higher; Hormel Foods Cuts Earnings Outlook
Benzinga via Yahoo Finance
27 Dec 2021
|
|
... C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With...
WFMZ Eastern Pennsylvania and Western New Jersey
6 Dec 2021
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$8.69M |
| EBIT | -$8.70M |
| Net Income | -$8.70M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -1.20K% |
| ROE | 122.19% |
| Debt/Equity | -1.14 |
|---|---|
| Net debt/EBITDA | -1.22 |
| Current ratio | 0.05 |
| Quick ratio | 0.05 |